From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain.
Pascal CrépeyEsther RedondoJavier Díez-DomingoRaul Ortiz de Lejarazu-LeonardoFederico Martinón-TorresÁngel Gil de MiguelJuan Luis López-BelmonteFabián P AlvarezHélène BricoutMíriam SolozabalPublished in: PloS one (2020)
Our results show public health and economic benefits for influenza prevention with QIV. It would be an efficient intervention for the Spanish National Health Service with major health benefits especially in the population ≥65-year.